Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000

Shelah Leader1, Kimmie Kohlhase

  • 1MedImmune, Inc, Gaithersburg, Maryland 20878, USA. Leaders@MedImmune.com

The Journal of Pediatrics
|November 15, 2003
PubMed

Insights

Severe respiratory syncytial virus (RSV) infections cause significant infant illness and death in the US. Infants of black mothers, Medicaid recipients, and those born prematurely or with low birth weight face the highest risks.

Area of Science:

  • Pediatric Infectious Diseases
  • Public Health Surveillance
  • Health Economics

Background:

  • Respiratory syncytial virus (RSV) is a primary cause of severe lower respiratory tract infections in infants.
  • Estimating the full burden of RSV, including incidence, risk factors, and economic impact, is crucial for public health planning.

Purpose of the Study:

  • To determine the incidence, risk factors, and associated costs of severe RSV infections in US infants.
  • Severe RSV was defined by emergency department (ED) visits, hospitalizations, and mortality.

Main Methods:

  • Retrospective analysis of national healthcare databases (1997-2000) including ED visits, hospitalizations, and mortality data.
  • Hospital charges and Medicare fee schedules were used to estimate economic costs.
  • US Census data provided population denominators for incidence calculations.

Main Results:

  • During 1997-2000, infants experienced 718,008 ED visits for lower respiratory infections during RSV season, with 29% requiring admission.
  • RSV bronchiolitis was the leading cause of infant hospitalization, with total charges exceeding $2.6 billion over 4 years.
  • An estimated 390 postneonatal deaths were associated with RSV in 1999, with prematurity and low birth weight increasing mortality risk.

Conclusions:

  • RSV represents a substantial burden of infant morbidity and mortality in the United States.
  • Infants of black mothers and those with Medicaid insurance had higher rates of severe RSV.
  • Prematurity and low birth weight are significant risk factors for RSV-associated mortality.
Abstract

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...